Generic Veramyst: An Overview
Veramyst™ (
fluticasone furoate nasal spray) is a prescription nasal spray used to treat nasal
allergies (known medically as allergic rhinitis). It belongs to a group of medications known as corticosteroids (or simply "steroids" for short).
Veramyst is manufactured by GlaxoSmithKline. It is currently under the protection of a patent that prevents any generic Veramyst from being manufactured in the United States. It is important to note that generic
fluticasone propionate nasal spray is not a generic version of Veramyst (it is a generic version of
Flonase®, a similar medication).
When Will Generic Veramyst Be Available?
The first patent for Veramyst currently expires in August 2021. This is the earliest possible date that a generic version of Veramyst could become available. However, there are other circumstances that could come up to extend the exclusivity period of Veramyst beyond 2021. This could include such things as other patents for specific
Veramyst uses or lawsuits. Once Veramyst goes off patent, there may be several companies that will begin manufacturing a generic Veramyst drug.
Flonase nasal spray is available in generic versions, while Veramyst is not. Many people wonder if there is a difference between these two medications. Both medications contain fluticasone. However, there are some important differences. Veramyst (but not Flonase) has been shown to improve eye
allergy symptoms, such as redness, itching, and wateriness. Also, Veramyst is approved for use in children as young as two years old, while Flonase is approved for children age four and older. However, Flonase is approved to treat non-allergic nasal symptoms, while Veramyst is not.